Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer
Clinical trial NCT00005648 · COMPLETED
Trial details
- NCT number
- NCT00005648
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-11-01
- Enrollment
- 688
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.